The most effective way to tackle debilitating diseases is to punch them at the start and keep them from growing.
Research at Michigan State University, published in the Journal of Biological Chemistry, shows that a small “molecular tweezer” keeps proteins from clumping, or aggregating, the first step of neurological disorders such as Parkinson’s disease, Alzheimer’s disease and Huntington’s disease.
The results are pushing the promising molecule toward clinical trials and actually becoming a new drug, said Lisa Lapidus, MSU associate professor of physics and astronomy and co-author of the paper.
“By the time patients show symptoms and go to a doctor, aggregation already has a stronghold in their brains,” she said. “In the lab, however, we can see the first steps, at the very place where the drugs could be the most effective. This could be a strong model for fighting Parkinson’s and other diseases that involve neurotoxic aggregation.”
Lapidus’ lab uses lasers to study the speed of protein reconfiguration before aggregation, a technique Lapidus pioneered. Proteins are chains of amino acids that do most of the work in cells. Scientists understand protein structure, but they don’t know how they are built – a process known as folding.
Lapidus’ lab has shed light on the process by correlating the speed at which an unfolded protein changes shape, or reconfigures, with its tendency to clump or bind with other proteins. If reconfiguration is much faster or slower than the speed at which proteins bump into each other, aggregation is slow, but if reconfiguration is the same speed, aggregation is fast.
Srabasti Acharya, lead author and doctoral candidate in Lapidus’ lab, tested the molecule, CLR01, which was patented jointly by researchers at the University of Duisburg-Essen (Germany) and UCLA. CLR01 binds to the protein and prevents aggregation by speeding up reconfiguration. It’s like a claw that attaches to the amino acid lysine, which is part of the protein.
This work was preceded by Lapidus’ research involving the spice curcumin. While the spice molecules put the researchers on a solid path, the molecules weren’t viable drug candidates because they cannot cross the blood-brain barrier, or BBB, the filter that controls what chemicals reach the brain.
It’s the BBB, in fact, that disproves the notion that people should simply eat more spicy food to stave off Parkinson’s disease.
Spicy misconceptions notwithstanding, CLR01 mimics curcumin molecules’ ability to prevent aggregation. But unlike the spice, CLR01 can crossover the BBB and treat its targeted site. Not only do they go to the right place, but CLR01 molecules also work even better because they speed up reconfiguration even more than curcumin. Additionally Acharya showed that CLR01 slows the first step of aggregation, and the results from the study map out a clear road map for moving the drug to clinical trials.
Hearing about a nontraditional physics lab that was advancing medicine is what brought Acharya to work with Lapidus.
“I knew I wanted to study physics when I came to MSU, but when I heard Dr. Lapidus’ presentation during orientation, I knew this is what I wanted to do,” Acharya said. “We are using physics to better understand biology to help cure actual diseases.”
To help move the research to the next phase, Gal Bitan, co-author and professor at UCLA, is using crowdsourcing to raise funds for the clinical trials. Log on to the indiegogo.com website for more information.
The Latest on: Parkinson’s
via Google News
The Latest on: Parkinson’s
- PTC Therapeutics launches study of Parkinson's candidateon July 8, 2020 at 1:26 pm
(PTCT +1.1%) has dosed first subject in Phase 1 trial for PTC857, an investigational small molecule that inhibits 15-Lipoxygenase, an enzyme that regulates the inflammation and oxidative stress that ...
- American Dance Festival Receives Renewed Funding for Parkinson's Projectson July 8, 2020 at 10:59 am
The American Dance Festival has announced that it has been awarded funding to continue its Parkinson's projects for 2020-21.
- Mice ‘cured’ of Parkinson’s in accidental scientific discoveryon July 8, 2020 at 10:45 am
Mice were “cured” of Parkinson’s disease after a scientific study took an unexpected turn. Scientists from the University of California (UC) in San Diego set out to better understand the role of ...
- Parkinson's boxing program moves to Ringgoldon July 8, 2020 at 10:01 am
The national Parkinson's Foundation estimates there are nearly 1 million people living with the degenerative disease across the country. According to Kristen Schillaci, a local certified occupational ...
- Altered interhemispheric synchrony in Parkinson’s disease patients with levodopa-induced dyskinesiason July 8, 2020 at 2:05 am
Levodopa-induced dyskinesias are common motor complication of Parkinson’s disease after 4–6 years of treatment. The hallmarks of dyskinesias include unilateral onset and the tendency to appear on the ...
- Opinion: Health care got my attention when Parkinson’s did, support candidates with plans for affordable careon July 8, 2020 at 1:23 am
Health care became political for me in the fall of 2016, when I received a diagnosis of Parkinson’s disease at the age of 48. Prior to this diagnosis, like many people who enjoy stable employment, ...
- Parkinson's Disease Treatment Market Future Scope, Opportunities with Strategic Growth and Top Playerson July 7, 2020 at 8:46 am
The report covers the forecast and analysis of the Parkinson's Disease Treatment Market on a global and regional level.
- Parkinson's Foundation Announces Results of PD GENEration Pilot Studyon July 7, 2020 at 6:05 am
NEW YORK and MIAMI, July 7, 2020 /PRNewswire/ -- The Parkinson's Foundation today announced the preliminary results from the PD GENEration: Mapping the Future of Parkinson's Disease pilot study. PD ...
- Parkinson's disease risk in Louisiana linked to use of two herbicides and a pesticide: studyon July 5, 2020 at 5:30 pm
A new study of individuals treated for Parkinson’s disease in Louisiana found a clear correlation between the disease and the use of two types of herbicide and one pesticide in ...
- A third of people with Parkinson's have experienced increased symptoms during lockdownon July 3, 2020 at 5:46 am
A third of people with Parkinson's have experienced increased symptoms during lockdown, according to a survey by Lancaster University and the charity Parkinson's UK.
via Bing News